Carr Financial Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Carr Financial Group's BMY Position: Q1 2025 in Review
Carr Financial Group sold out of Bristol-Myers Squibb (BMY) in Q1 2025, closing a stake of 4,643 shares — an estimated $263K sold.
Carr Financial Group first reported a position in BMY in Q4 2022 and held it in 3 quarters. The position peaked at $263K in Q4 2024. 2,477 funds tracked by Wall St. Rank hold BMY as of Q1 2025.
- Carr Financial Group reported no remaining Bristol-Myers Squibb position as of Q1 2025 after selling out during the quarter.
- Carr Financial Group sold 4,643 Bristol-Myers Squibb shares in Q1 2025, an estimated $263K.
- Carr Financial Group first reported a position in Bristol-Myers Squibb in Q4 2022 and held it in 3 quarters.
- Carr Financial Group's Bristol-Myers Squibb position peaked at $263K in Q4 2024.
- 2,477 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2025.
Based on Carr Financial Group's 13F filing for Q1 2025, filed 22 Apr 2025.